Skip to content

The Epigenetics of Exercise and Physical Activity in COPD

The Epigenetics of Exercise and Physical Activity in COPD

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03539042
Enrollment
50
Registered
2018-05-29
Start date
2018-03-01
Completion date
2021-06-30
Last updated
2018-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Copd

Keywords

DNA methylation, Physical activity, Exercise capacity

Brief summary

This study seeks to examine genome-wide DNA methylation patterns associated with physical activity and exercise capacity from peripheral blood collected from participants with chronic obstructive pulmonary disease (COPD) before and after participation in a structured 9-week outpatient pulmonary rehabilitation program.

Detailed description

Individuals who are referred to pulmonary rehabilitation IN THE COURSE OF THEIR USUAL CLINICAL CARE will be invited to participate in this observational study. Participants who enroll in the study will undergo two in-person visits, once before initiating pulmonary rehabilitation classes and once at the conclusion of pulmonary rehabilitation classes. Participation in this study will not alter the course of the participants' usual clinical care.

Interventions

None listed

Sponsors

VA Boston Healthcare System
Lead SponsorFED

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>40 years * Diagnosis of COPD (defined as an FEV1/FVC\<0.7 or evidence of emphysema on radiologist's read of a chest CT obtained in the course of patient's usual care) * Referral to and participation in the VA Boston Pulmonary Rehabilitation program

Exclusion criteria

* Active or unstable cardiac disease * Inability to ambulate \> 1 block * Recent acute exacerbation of COPD (defined as new or increased dose of systemic steroids and/or antibiotics for pulmonary indications)

Design outcomes

Primary

MeasureTime frameDescription
Change in DNA methylation patternsBaseline and 3-month follow upBaseline patterns and changes over time after participation in exercise training

Secondary

MeasureTime frameDescription
Change in 6MWDBaseline and 3-month follow upChange in exercise capacity (assessed as 6 minute walk distance) after exercise training in pulmonary rehabilitation
Change in average daily step countBaseline and 3-month follow upChange in pedometer assessed daily step count before and after exercise training in pulmonary rehabilitation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026